Kestra Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Kestra Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-44	Closed	-$5.8K	–	995
2025 Q1	$5.8K	Sell	44 -8	-15%	-$997	﹤0.01%	669
2024 Q4	$4.34K	Buy	+52	New	+$4.27K	﹤0.01%	927

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Kestra Investment Management's ITCI Position: Q2 2025 in Review

Kestra Investment Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 44 shares — an estimated $5.8K sold.

Kestra Investment Management first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $5.8K in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Kestra Investment Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Kestra Investment Management sold 44 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.8K.
Kestra Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
Kestra Investment Management's Intra-Cellular Therapies Inc. position peaked at $5.8K in Q1 2025.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Kestra Investment Management's 13F filing for Q2 2025, filed 15 Aug 2025.